Snapshot from Aug 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Business acquisition

SuanNutra acquires IFF specialty ingredients

Analysis based on 14 articles · First reported Jul 20, 2026 · Last updated Jul 20, 2026

Sentiment
15
Attention
2
Articles
14
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The acquisition positions SuanNutra as a larger player in the natural ingredients market, potentially increasing its competitiveness and revenue. IFF's divestiture aligns with its focus on core businesses, and the deal may positively impact SuanNutra's valuation and Carbyne's investment returns.

food ingredients nutraceuticals specialty chemicals

SuanNutra, a portfolio company of Carbyne Equity Partners, has signed an agreement to acquire a portfolio of specialty natural ingredients businesses from IFF (NYSE: IFF). The acquired businesses will merge with SuanNutra's existing operations to create an enlarged global group in science-backed natural ingredients. The transaction is expected to close by the end of 2026, subject to regulatory clearances and customary closing conditions. Financial terms were not disclosed, but IFF reported that the acquired portfolio generated approximately US$170 million in revenue in 2025. The combined manufacturing footprint includes botanical extraction in Spain, Slovenia, and Peru, and fermentation in the United States. The merged group will have around 700 employees serving over 1,200 customers in more than 60 countries. The acquisition strengthens SuanNutra's Visible Health strategy and expands its portfolio into food-enhancement ingredients such as natural colors, antioxidants, and flavors. SuanNutra also recently finalized a distribution agreement with Spanish biotech company Fitoplancton Marino for its microalgae-based ingredient TetraSOD in North America.

100 SuanNutra signed agreement to acquire International Flavors & Fragrances
30 SuanNutra finalized distribution agreement Fitoplancton Marino
priv
SuanNutra is the acquirer, expanding its product portfolio and manufacturing footprint, strengthening its position in natural ingredients.
Importance 100.0 Sentiment 60.0
stock
IFF is the seller, divesting a portfolio of natural ingredients businesses as part of its strategic refocusing.
Importance 90.0 Sentiment 30.0
priv
Carbyne is the private equity owner backing the acquisition, deepening its focus on specialty ingredients.
Importance 80.0 Sentiment 50.0
per
Anthony Weston is the Group CEO of SuanNutra, leading the acquisition and integration.
Importance 40.0 Sentiment 0.0
per
Eli Glickman is the Non-Executive Chairman of SuanNutra, supporting the strategic direction.
Importance 30.0 Sentiment 0.0
per
Markus Petersen is the Managing Partner of Carbyne Equity Partners, backing the deal.
Importance 30.0 Sentiment 0.0
cnt
The United States hosts fermentation operations of the combined group.
Importance 20.0 Sentiment 0.0
per
Mai Karas is the Investment Director of Carbyne Equity Partners, involved in the transaction.
Importance 20.0 Sentiment 0.0
priv
Fitoplancton Marino entered a distribution agreement with SuanNutra for its microalgae ingredient TetraSOD.
Importance 20.0 Sentiment 10.0
cnt
Spain hosts botanical extraction facilities of the combined group.
Importance 20.0 Sentiment 0.0
priv
Herbert Smith Freehills Kramer acted as legal counsel to SuanNutra and Carbyne.
Importance 10.0 Sentiment 0.0
priv
EY acted as financial advisor to SuanNutra and Carbyne.
Importance 10.0 Sentiment 0.0
priv
Alantra acted as financial advisor to IFF.
Importance 10.0 Sentiment 0.0
priv
DLA Piper LLP acted as legal counsel to IFF.
Importance 10.0 Sentiment 0.0
cnt
Slovenia hosts botanical extraction facilities of the combined group.
Importance 10.0 Sentiment 0.0
+ 1 more entities View on Dashboard
United States related Spain
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.